Mobocertinib/Mobocertinib usage and dosage

Mobocertinib/Mobocertinib(Mobocertinib) is developed by Takeda Corporation of Japan. Mobocertinib is used in adult patients. EGFRExon20Insertion mutation-Positive, locally advanced or metastatic non-small cell lung cancer in which the disease has progressed on or after platinum-based chemotherapy.

The recommended adult dose of mobosetinib is 160 mg once daily, continued until disease progression or unacceptable toxicity occurs. Swallow capsule whole when taking. Do not open or chew or dissolve capsule contents. If a dose is missed by more than 6 hours or if vomiting occurs, do not double the dose or take an extra dose. Take the next dose at the prescribed time. Adverse reactions may require temporary interruption of treatment, dose reduction, or discontinuation. If interstitial lung disease or pneumonitis occurs, permanently discontinue treatment. If intolerable Grade 2 or Grade 3 diarrhea occurs, interrupt treatment with mobotinib until toxicity improves to Grade 1 or less, then continue treatment at the same or reduced dose. If grade 4 diarrhea occurs, interrupt mobotinib treatment until toxicity improves to grade 1 or less, then continue treatment at a reduced dose. If grade 4 diarrhea recurs, permanently discontinue treatment. If any other intolerable or recurrent grade 2 or grade 3 toxicity occurs, interrupt mobotinib treatment until the toxicity improves to grade 1 or less, then continue treatment at the same or reduced dose. If any other grade 4 toxicity occurs, interrupt mobotinib treatment until the toxicity improves to grade 1 or less. If recovery occurs within 2 weeks, reduce mobotinib dose. If recovery does not occur within 2 weeks, discontinue medication permanently. For recurrence of grade 4 toxicity, permanently discontinue mobotinib. If concomitant use with moderateCYP3A4inhibitors cannot be avoided, thenMobotinibdose was reduced by approximately 50% (i.e. from 160 to 80 mg, 120 to 40 mgor 80 to 40 mg). After discontinuing the moderateCYP3Ainhibitor for 3-5 elimination half-lives, resume the previousmobotinib dose. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.